Skip to content

LARCHON MEDICA

Active
Private limited companyfounded 2024active for 2 yearsRue du Marais 31, 7160 Chapelle-lez-Herlaimont, BelgiumKBO/BCE: BE 1014.116.192
Summary

LARCHON MEDICA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €84,395 and a net result of €79,395. The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Official details

Source: KBO
Status
Active since 25-09-2024 Normal situation
Activity
“L'exercice de la médecine et ce, par ses organes médecins légalement habilités à pratiquer…” (deed in French)From the articles, 5 activitiesNo NACE code in the KBO yet
Establishment unit
2.364.555.043 7160 Chapelle-lez-Herlaimont, since 25-09-2024
Financial year end
31 December
Peppol
Reachable since 10-12-2025

Board and ownership

Board

Financial position

89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Annual accounts 2025
Gross margin
€100,039
Turnover
≈ €250,000
estimated
Profit
€79,395
Equity
€84,395
Total assets
€87,742
Score breakdownraises riskFounded in 2024No main activity registeredlowers riskLiquidity: current ratio 26.21, cash €83,195Equity €84,395 (96.2% of total assets)Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 89% of micro companies without a NACE code
Financial strength
Strong
Solvency 100
equity 96.2% of total assets
Liquidity 100
short-term debt 3.8% · cash 94.8%
Profitability 100
return on assets 90.5%
Bankruptcy probability within 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 10-2025: 2.4% 11-2025: 2.4%● unchanged vs 10-2025 12-2025: 2.5%▲ +0.1 percentage points vs 11-2025 01-2026: 2.9%▲ +0.4 percentage points vs 12-2025 02-2026: 3.0%▲ +0.1 percentage points vs 01-2026 03-2026: 3.3%▲ +0.3 percentage points vs 02-2026 04-2026: 3.3%● unchanged vs 03-2026 05-2026: 3.6%▲ +0.3 percentage points vs 04-2026highest value 06-2026: 3.5%▼ -0.1 percentage points vs 05-2026 07-2026: 0.3%▼ -3.2 percentage points vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026lowest value 10-2026: 0.4%▲ +0.1 percentage points vs 09-2026 11-2026: 0.4%● unchanged vs 10-2026
Credit of up to €7,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 26.21, above the usual 1.5. Short-term debt is 3.8% and cash 94.8% of total assets. 3.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 95% on liquidity and 90% on profitability.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 26.21, cash €83,195
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · No main activity registered
KBO
lowers risk · Equity €84,395 (96.2% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-06-2026, 53 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
53 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Recent changes

  1. · Gazette deed IncorporationStarting capital €5,000 · Appointment: LÉONARD Corentin, Maurice, Jean-Claude (director)
All 2 events

Key facts about LARCHON MEDICA

What is the company number of LARCHON MEDICA?
The company number of LARCHON MEDICA is 1014.116.192. The VAT number is the same number with BE in front: BE 1014.116.192.
Where is LARCHON MEDICA based?
The registered office is at Rue du Marais 31, 7160 Chapelle-lez-Herlaimont.Company details
What is the legal form of LARCHON MEDICA?
The legal form of LARCHON MEDICA is Private limited company (BV).
When was LARCHON MEDICA founded?
LARCHON MEDICA was founded on 25-09-2024.
Is LARCHON MEDICA still active?
Yes, LARCHON MEDICA is an active enterprise in the KBO register.
What is the turnover of LARCHON MEDICA?
The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €100,039 and 2,215 comparable companies of the same size. It probably lies between €170,000 and €390,000. It is a rough estimate.Financials
Is LARCHON MEDICA profitable?
In financial year 2025, LARCHON MEDICA made a profit of €79,395.
Where can I find the annual accounts of LARCHON MEDICA?
LARCHON MEDICA filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.